The Ribosomal Protein RPLP0 Mediates PLAAT4-induced Cell Cycle Arrest and Cell Apoptosis. 2019

Chun-Hua Wang, and Lu-Kai Wang, and Chang-Chieh Wu, and Mao-Liang Chen, and Ming-Cheng Lee, and Yi-Ying Lin, and Fu-Ming Tsai
Department of Dermatology, Taipei Tzuchi Hospital, Buddhist Tzuchi Medical Foundation, 231, New Taipei City, Taiwan.

Phospholipase A and acyltransferase 4 (PLAAT4) is a member of the HREV107 tumor suppressor gene family. The expression of PLAAT4 has been shown to induce cell death; however, the underlying mechanism remains unknown. Here, we found that RPLP0, a ribosomal protein, can interact with PLAAT4, as determined by yeast two-hybrid screening, coimmunoprecipitation, and colocalization. The level of RPLP0 was suppressed in HtTA cervical cancer cells expressing PLAAT4. In PLAAT4-expressing or RPLP0-silenced cells, decreased cell viability and cell proliferation combined with increased cell death were observed. Furthermore, the levels of cell cycle-associated proteins and anti-apoptotic proteins decreased in PLAAT4-expressing or RPLP0-silenced cells. Similar patterns of cell viability and expression levels of cell-cycle-associated proteins and apoptosis-related proteins were observed in PLAAT4-expressing and RPLP0-knockdown cells, indicating that RPLP0 deficiency might be involved in PLAAT4-mediated growth inhibition and cellular apoptosis.

UI MeSH Term Description Entries
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012269 Ribosomal Proteins Proteins found in ribosomes. They are believed to have a catalytic function in reconstituting biologically active ribosomal subunits. Proteins, Ribosomal,Ribosomal Protein,Protein, Ribosomal
D016213 Cyclins A large family of regulatory proteins that function as accessory subunits to a variety of CYCLIN-DEPENDENT KINASES. They generally function as ENZYME ACTIVATORS that drive the CELL CYCLE through transitions between phases. A subset of cyclins may also function as transcriptional regulators. Cyclin
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D059447 Cell Cycle Checkpoints Regulatory signaling systems that control the progression through the CELL CYCLE. They ensure that the cell has completed, in the correct order and without mistakes, all the processes required to replicate the GENOME and CYTOPLASM, and divide them equally between two daughter cells. If cells sense they have not completed these processes or that the environment does not have the nutrients and growth hormones in place to proceed, then the cells are restrained (or "arrested") until the processes are completed and growth conditions are suitable. Cell Cycle Arrest,Cell Cycle Control,Cell Cycle Transition Points,Cell Cycle-Transition Points,Arrest, Cell Cycle,Arrests, Cell Cycle,Cell Cycle Arrests,Cell Cycle Checkpoint,Cell Cycle Controls,Cell Cycle-Transition Point,Checkpoint, Cell Cycle,Checkpoints, Cell Cycle,Control, Cell Cycle,Controls, Cell Cycle,Cycle-Transition Point, Cell,Point, Cell Cycle-Transition
D018168 Receptors, Retinoic Acid Proteins in the nucleus or cytoplasm that specifically bind RETINOIC ACID or RETINOL and trigger changes in the behavior of cells. Retinoic acid receptors, like steroid receptors, are ligand-activated transcription regulators. Several types have been recognized. Retinoic Acid Receptors,Retinoic Acid-Binding Proteins,Retinoic Acid Receptor,Proteins, Retinoic Acid-Binding,Receptor, Retinoic Acid,Retinoic Acid Binding Proteins
D018844 Cyclin-Dependent Kinases Protein kinases that control cell cycle progression in all eukaryotes and require physical association with CYCLINS to achieve full enzymatic activity. Cyclin-dependent kinases are regulated by phosphorylation and dephosphorylation events. Cyclin-Dependent Kinase,Cyclin-Dependent Protein Kinase,cdk Proteins,Cyclin-Dependent Protein Kinases,Cyclin Dependent Kinase,Cyclin Dependent Kinases,Cyclin Dependent Protein Kinase,Cyclin Dependent Protein Kinases,Kinase, Cyclin-Dependent,Kinase, Cyclin-Dependent Protein,Protein Kinase, Cyclin-Dependent
D019253 Proto-Oncogene Proteins c-bcl-2 Membrane proteins encoded by the BCL-2 GENES and serving as potent inhibitors of cell death by APOPTOSIS. The proteins are found on mitochondrial, microsomal, and NUCLEAR MEMBRANE sites within many cell types. Overexpression of bcl-2 proteins, due to a translocation of the gene, is associated with follicular lymphoma. bcl-2 Proto-Oncogene Proteins,c-bcl-2 Proteins,B-Cell Leukemia 2 Family Proteins,BCL2 Family Proteins,BCL2 Proteins,B Cell Leukemia 2 Family Proteins,Family Proteins, BCL2,Proteins, BCL2,Proteins, BCL2 Family,Proto Oncogene Proteins c bcl 2,Proto-Oncogene Proteins, bcl-2,bcl 2 Proto Oncogene Proteins,c bcl 2 Proteins,c-bcl-2, Proto-Oncogene Proteins
D034622 RNA Interference A gene silencing phenomenon whereby specific dsRNAs (RNA, DOUBLE-STRANDED) trigger the degradation of homologous mRNA (RNA, MESSENGER). The specific dsRNAs are processed into SMALL INTERFERING RNA (siRNA) which serves as a guide for cleavage of the homologous mRNA in the RNA-INDUCED SILENCING COMPLEX. DNA METHYLATION may also be triggered during this process. Gene Silencing, Post-Transcriptional,Post-Transcriptional Gene Silencing,Co-Suppression,Cosuppression,Posttranscriptional Gene Silencing,RNA Silencing,RNAi,Co Suppression,Gene Silencing, Post Transcriptional,Gene Silencing, Posttranscriptional,Gene Silencings, Posttranscriptional,Interference, RNA,Post Transcriptional Gene Silencing,Post-Transcriptional Gene Silencings,Silencing, Post-Transcriptional Gene

Related Publications

Chun-Hua Wang, and Lu-Kai Wang, and Chang-Chieh Wu, and Mao-Liang Chen, and Ming-Cheng Lee, and Yi-Ying Lin, and Fu-Ming Tsai
December 2013, Journal of virology,
Chun-Hua Wang, and Lu-Kai Wang, and Chang-Chieh Wu, and Mao-Liang Chen, and Ming-Cheng Lee, and Yi-Ying Lin, and Fu-Ming Tsai
December 2005, Biochemical and biophysical research communications,
Chun-Hua Wang, and Lu-Kai Wang, and Chang-Chieh Wu, and Mao-Liang Chen, and Ming-Cheng Lee, and Yi-Ying Lin, and Fu-Ming Tsai
April 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Chun-Hua Wang, and Lu-Kai Wang, and Chang-Chieh Wu, and Mao-Liang Chen, and Ming-Cheng Lee, and Yi-Ying Lin, and Fu-Ming Tsai
November 1998, Clinical cancer research : an official journal of the American Association for Cancer Research,
Chun-Hua Wang, and Lu-Kai Wang, and Chang-Chieh Wu, and Mao-Liang Chen, and Ming-Cheng Lee, and Yi-Ying Lin, and Fu-Ming Tsai
March 2000, Molecular cell,
Chun-Hua Wang, and Lu-Kai Wang, and Chang-Chieh Wu, and Mao-Liang Chen, and Ming-Cheng Lee, and Yi-Ying Lin, and Fu-Ming Tsai
January 2002, Springer seminars in immunopathology,
Chun-Hua Wang, and Lu-Kai Wang, and Chang-Chieh Wu, and Mao-Liang Chen, and Ming-Cheng Lee, and Yi-Ying Lin, and Fu-Ming Tsai
February 2005, Cancer letters,
Chun-Hua Wang, and Lu-Kai Wang, and Chang-Chieh Wu, and Mao-Liang Chen, and Ming-Cheng Lee, and Yi-Ying Lin, and Fu-Ming Tsai
November 2001, Molecular and cellular biology,
Chun-Hua Wang, and Lu-Kai Wang, and Chang-Chieh Wu, and Mao-Liang Chen, and Ming-Cheng Lee, and Yi-Ying Lin, and Fu-Ming Tsai
January 2020, Advanced pharmaceutical bulletin,
Chun-Hua Wang, and Lu-Kai Wang, and Chang-Chieh Wu, and Mao-Liang Chen, and Ming-Cheng Lee, and Yi-Ying Lin, and Fu-Ming Tsai
March 2014, Journal of cancer prevention,
Copied contents to your clipboard!